Relationship between spine osteoarthritis, bone mineral density and bone turn over markers in post menopausal women.
BACKGROUND
Several studies have observed an inverse relationship between osteoporosis and spinal osteoarthritis, the latter being considered as possibly delaying the development of osteoporosis. The aim of this study was to determine the association between individual radiographic features of spine degeneration, bone mineral density (BMD) and bone-turn over markers.


METHODS
It was a cross sectional study of 277 post menopausal women. BMD of all patients was assessed at the spine and hip using dual-energy X-ray absorptiometry. Lateral spinal radiographs were evaluated for features of disc degeneration. Each vertebral level from L1/2 to L4/5 was assessed for the presence and severity of osteophytes and disc space narrowing (DSN). For Bone turn-over markers, we assessed serum osteocalcin and C-terminal cross-linking telopeptide of type I collagen (CTX). Linear regressions and partial correlation were used respectively to determine the association between each of disc degeneration features, BMD, and both CTX and osteocalcin.


RESULTS
Mean age of patients was 58.7 +/- 7.7 years. Eighty four patients (31.2%) were osteoporotic and 88.44% had spine osteoarthritis. At all measured sites, there was an increase in BMD with increasing severity of disc narrowing while there was no association between severity of osteophytes and BMD. After adjustment for age and BMI, there was a significant negative correlation between CTX and DSN. However, no significant correlation was found between CTX and osteophytes and between osteocalcin and both osteophytes or DSN.


CONCLUSIONS
In post menopausal women the severity of disc narrowing, but not osteophytes, is associated with a generalized increase in BMD and a decreased rate of bone resorption. These results are consistent with the hypothesis that osteoarthritis, through DSN, has a protective effect against bone loss, mediated by a lower rate of bone resorption. However, spine BMD is not a relevant surrogate marker for the assessment of osteoporosis in the spine in patients with osteoarthritis and debate as to the relationship between OA and OP is still open because of the contradictory data in the literature.
Ichchou
Linda
L
Laboratory of Information and Research on Bone Diseases LIRPOS, Department of Rheumatology, El Ayachi hospital, University Hospital of Rabat-Sale, Morocco. ilinda19@yahoo.fr
Allali
Fadoua
F
Rostom
Samira
S
Bennani
Loubna
L
Hmamouchi
Ihsane
I
Abourazzak
Fatima Z
FZ
Khazzani
Hamza
H
El Mansouri
Laila
L
Abouqal
Redouane
R
Hajjaj-Hassouni
Najia
N
D015502:Absorptiometry, Photon; D015415:Biomarkers / Q000097:blood; D015519:Bone Density / Q000502:physiology*; D001862:Bone Resorption; D001842:Bone and Bones / Q000378:metabolism*; D024042:Collagen Type I; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D016014:Linear Models; D008875:Middle Aged; D055013:Osteoarthritis, Spine / Q000097:blood / Q000378:metabolism* / Q000473:pathology; D015675:Osteocalcin / Q000097:blood; D015663:Osteoporosis, Postmenopausal / Q000097:blood / Q000378:metabolism* / Q000473:pathology; D010446:Peptide Fragments / Q000097:blood; D010455:Peptides; D017698:Postmenopause / Q000097:blood / Q000378:metabolism*; D011347:Procollagen / Q000097:blood
D015415:Biomarkers; D024042:Collagen Type I; D010446:Peptide Fragments; D010455:Peptides; D011347:Procollagen; C052929:collagen type I trimeric cross-linked peptide; D015675:Osteocalcin